SARAH SIMMONS: Open Payments
NPI 1316647811 · OREM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 11 payments from 8 companies in 2025. Trend: 2023 $436 · 2024 $63 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 2 | $139 |
| ABBVIE INC. | 3 | $71 |
| Innovation Technologies Inc | 1 | $31 |
| Ethicon US, LLC | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| Neurelis, Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
Products named: UBRELVY, IRRISEPT, VISTASEAL, KESIMPTA, VALTOCO, Symbravo, INGREZZA.
Industry payments across UT — which companies pay providers there.
